Research & KnowledgeEvent: September 4, 2026
CureSHANK is actively working with experts to evaluate promising biomarker approaches for PMS therapy development.
Published
Signal category
Research & Knowledge
Quote
“CureSHANK is actively working with experts to evaluate promising biomarker approaches that will provide more accurate and objective measurements for PMS research”
— CureSHANK team
Company
CureSHANK
Relentlessly focused on turning promising science into life-transforming therapies for Phelan-McDermid syndrome.
- Industry
- Research Services
- Location
- Beverly Hills, US
- Company size
- 13 employees
CureSHANK is a nonprofit foundation whose mission is to accelerate the development of treatments for SHANK-associated disorders, specifically Phelan-McDermid Syndrome. Our approach is to identify and fund projects that overcome critical barriers to successful drug development and to coordinate scientific efforts to improve efficiency and speed in the field.
Founded 2019